Recipharm
Entry
2021
Hold
5yr
Status
Active
Who owns Recipharm?
Recipharm is currently owned by CIC Private Debt through CM-CIC Debt Fund 3 (2019 vintage), since 2021. Across its history, Recipharm has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
CIC Private DebtCM-CIC Debt Fund 3 · 2019 · Private Debt
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
CIC Private DebtActive
2021 · present(5yr) · CM-CIC Debt Fund 3 · 2019 · Private Debt
ArdianActive
2021 · present(5yr) · Ardian Co-Investment Fund V · 2019 · Buyout
More from CM-CIC Debt Fund 3
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Laboratoires Delbert
Active
Socadif
France
AMW
Active
SHS Gesellschaft für Beteiligungsmanagement
Germany· 2026
Basic Pharma
Active
SHS Gesellschaft für Beteiligungsmanagement
Netherlands· 2026
Cinclus Pharma
Active
Claret Capital Partners
Sweden· 2026
InfoRLife
Active
BC Partners
Switzerland· 2026
IRAB
Active
ARCHIMED
Spain· 2026
Track Recipharm
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Recipharm.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue